Eurofins-Cerep SA (ALECR.PA)
Paris · EUR · Healthcare · Diagnostics & Research
€18,400.00 (+0.00%) as of
Key statistics
- Market cap
- 92.81M
- P/E (TTM)
- 11.95
- EPS (TTM)
- 1,540.14
- Dividend yield
- 0.00%
- 52-week range
- 15,000.00 – 18,600.00
- Beta
- 0.11
- Revenue (TTM)
- 41.1M
- Profit margin
- 11.64%
- Volume
- 3.00
About Eurofins-Cerep SA
Eurofins-Cerep SA provides various drug discovery services to pharmaceutical, biopharmaceutical, and biotechnology companies France and internationally. The company also provides research services, including compound management, and high-throughout screening and profiling. The company was formerly known as Cerep SA and changed its name to Eurofins-Cerep SA in June 2014. Eurofins-Cerep SA was founded in 1989 and is based in Celle-Lévescault, France. Eurofins-Cerep SA is a subsidiary of Eurofins Discovery Services LUX Holding SARL.
- Sector
- Healthcare
- Industry
- Diagnostics & Research
- Headquarters
- Celle-Lévescault, France
Financial statements (income statement, balance sheet, cash flow) and an interactive price chart are available on this page with JavaScript enabled.